Lithium Carbonate Relieves the Symptoms of Major Depressive Episodes
Lithium carbonate is an inorganic chemical that is used in the production of metal oxides as well as a medication to treat mood disorders. This lithium carbonate salt is included on the World Health Organization’s List of Essential Medicines. White salt is also commonly utilised in the manufacture of lithium-ion batteries.
Lithium carbonate has been shown to be useful in alleviating the symptoms of major depression episodes and is mostly used to treat bipolar disorder. According to a 2018 study published in Therapeutic Advances in Psychopharmacology, the lifetime prevalence of bipolar disorder was 2.4 percent in one survey of 11 nations. The prevalence of bipolar type I was 1% in the United States. In individuals who receive lithium carbonate medication for at least six months, there is a significant improvement. It has the potential to dramatically improve the patient’s quality of life and reduce manic episodes.Patients who take Lithium Carbonate for treatment of bipolar disorder experience a significant improvement in their ability to carry out their daily activities and experience significant reductions in both their sadness and their elation.
Lithium carbonate tablets are film-coated and are indicated in the treatment of manic episodes of bipolar disorder. The tablets contain calcium stearate, microcrystalline cellulose, povidone, sodium lauryl sulfate, and sodium starch glycolate. It is also indicated as a maintenance treatment for individuals with a diagnosis of bipolar disorder. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes which may occur. A reduction in manic symptoms may be noticed within 5 to 7 days but the full therapeutic effect may require 10 to 21 days. Drowsiness, dizziness, tiredness, increased thirst, increased frequency of urination, weight gain, and mildly shaking hands (fine tremor) are some of the side effects of lithium carbonate. The tablets must not be given to patients with significant renal or cardiovascular disease, severe debilitation or dehydration, or sodium depletion. It may cause fetal harm when administered to a pregnant woman.
